The invention relates to 1-(2-deoxy-alpha-D-erythro-pentofuranosyl)-5-azacytosine of formula (I) for use as a hypomethylating drug applicable for epigenetic therapy of cancer and other epigenetically determined diseases and further includes the use of the compound of formula (I) for ...
Keep container closed when not in use. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Usega Chemical Product Shipping Marks According to Customer Requirements Content Standard Application Chemical Source Extractive Packing 25kgs Boiling Point 503.1ºC at 760 Mmhg Melting Point 300 ºC Transport Package by Foil - Alum Bag or...
The present invention relates to 1- (2-deoxy-伪-D-erythro-pentofuranosyl) -5-azacytosine of formula I for use as a drug inducing hypomethylation of DNA with potential use in epigenetic therapy of cancer and other epigenetically determined diseases and further includes the use of a compound of...
the solution relates to 1 - (2 - deoxy -. alpha.- d - erythro - pentofuranosyl) - 5 - azacytosinu formula for use as a lécivo inducing hypomethylaci dna with potential application in epigenetické therHOLY ANTONINBRTOV@EVAVOTRUBA IVAN...
Within the past 2鈥 3 years the use of specific gene probes along with digestion by the isoschizomeric restriction endonucleases Hpa II and Msp I has led to the concept that hypomethylation of specific gene probes along with digestion by the isoschizomeric restriction endonucleases Hpa II and ...
The invention relates to 1-(2-deoxy-alpha-D-erythro-pentofuranosyl)-5-azacytosine of formula (I) for use as a hypomethylating drug applicable for epigenetic therapy of cancer and other epigenetically determined diseases and further includes the use of the compound of formula (I) for ...